Decide what the consultation is for before you look at dates
A lymphoma consultation in China is a records-based clinical opinion, not a transfer of care. The Chinese clinician reviews your diagnosis, staging, pathology and treatment history, then discusses whether another option, a different sequencing, or a second opinion on the plan makes sense. That is a different request from asking a hospital to take over your treatment, and it changes what you prepare.
Lymphoma is not one disease. Hodgkin and non-Hodgkin lymphoma behave differently, and the exact subtype and stage shape which questions are worth asking. If your records do not yet establish the subtype clearly, the consultation may be more useful as a pathology or staging review than as a treatment discussion. Ask your current team which documents already answer that question.
Write down the one decision you want help with. Examples: whether the current plan is the right one for your subtype; whether a clinical trial or a different drug class is worth exploring; whether a transplant assessment is relevant at this stage. A vague request for a second opinion produces a vague answer, and it makes the trip harder to justify.
What the Chinese clinician needs to see, and what you should ask your current team for
The core file is the same one any lymphoma specialist would want: the pathology report with subtype and markers, imaging used for staging, treatment history with drugs and dates, and the most recent response assessment. Blood counts, organ function results and any complications from treatment belong in the summary too, because they affect what a clinician can safely suggest.
Ask your current treating team for a short clinical summary in English, not just a pile of scans and lab printouts. A summary that states the diagnosis, the treatment given so far, the response, and the open question is far more useful than raw files. If your records are in another language, ask whether an English translation is available; if not, say so when you enquire, because it affects how the review is arranged.
Do not send a complete medical archive at first contact. A brief summary of the diagnosis and your main question is enough to start. Once a route is agreed, you can share the specific documents the receiving clinician asks for. This keeps the process manageable and avoids sending sensitive material before there is a reason to.
- Pathology report naming the lymphoma subtype and relevant markers
- Staging imaging reports and the date they were done
- Treatment history: drugs, dates, cycles completed, and any changes
- Most recent response assessment and the date
- Recent blood counts, organ function and any treatment complications
- A one-page English summary from your current team stating the open question
Timing the trip around ongoing treatment
Confirm the timing with your current treating team before making travel arrangements. A consultation trip has to fit between treatment commitments, and the window depends on your regimen, your counts, and how you feel after the last dose. Your current treating team is the only group that can say whether travel is safe at a given point, and they should be asked directly rather than assumed.
Ask your current team three questions before you book anything: is there a window when travel would not interfere with treatment; are there restrictions on flying or long journeys at this point; and what would they want the Chinese clinician to know. The answers decide whether the trip is realistic now or better done remotely first.
A records-based opinion while you stay at home can answer many questions without travel. If the question is about whether a different approach is worth considering, a remote review may be enough to decide whether a visit is worthwhile. If the question requires an examination or a test that cannot be done from your records, that is when travelling becomes the sensible next step. Ask which of these applies to you before committing to flights.
What a China consultation can and cannot settle
A Chinese specialist can review your records, discuss the reasoning behind your current plan, and give an opinion on alternatives. That opinion is useful, but it does not by itself change your treatment, and it does not confirm that a particular therapy is available to you in China. Availability, suitability and any decision to treat belong to the treating hospital and licensed clinicians after they assess you.
Be careful with questions that sound simple but are not. Whether a drug is approved in China, whether a trial is open to international patients, and whether a transplant assessment is relevant are all separate questions with separate answers. Ask them explicitly, and expect the hospital to confirm rather than the coordination team.
If your current treatment is working and your team is satisfied, a second opinion may still be useful for reassurance or for planning ahead. If your disease is progressing, the priority is usually a prompt discussion with your current team about the next step, not an overseas trip. Urgent or worsening symptoms need local assessment first.
Practical arrangements that change the plan
Language is the first practical issue. Ask whether the consultation will be conducted in English, whether an interpreter is needed, and who arranges it. Interpretation during a complex oncology discussion is not optional, and the arrangement should be confirmed before the appointment rather than on the day.
Ask which hospital route is being proposed and why. Public tertiary hospitals and private international hospitals are different settings with different processes. Neither is automatically better for a lymphoma opinion; the question is whether the setting can provide the specific review you need and communicate it clearly.
Records transfer, appointment confirmation and follow-up all need to be agreed in writing. Ask what happens after the consultation: will you receive a written opinion, who sends it, and how will it reach your current team. A verbal discussion that never reaches your treating clinician has limited value.
Travel and local logistics matter, but they should follow the clinical decision, not lead it. Confirm the appointment and the records plan first, then arrange travel. If the trip depends on a treatment window that could change, build in flexibility rather than fixing everything in advance.
Questions to put to the provider before you commit
Ask what the consultation includes and what it does not. A records review, a specialist appointment and a multidisciplinary discussion are different services with different scopes. Ask which one is being proposed for your case and why.
Ask who reviews the records and what their role is. The answer should be a licensed clinician with relevant lymphoma experience, and the hospital should confirm this rather than the coordination team. Ask whether the opinion will be written and whether it can be shared with your current treating team.
Ask what the provider needs from you and by when, and what happens if a document is missing. Missing records should prompt a clear request, not a guess. Ask how the provider handles that situation before you pay for anything.
Finally, ask what the provider cannot do. A provider that is clear about limits is easier to work with than one that promises outcomes. Hospital acceptance, treatment suitability and clinical decisions are confirmed by the hospital after assessment, and no coordination service can confirm them in advance.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.